BCN Peptides is focused entirely on the Bulk cGMP manufacture of Bioactive Peptides by Solid Phase Synthesis. The company has been audited by US FDA and EDQM. BCN Peptides holds four Certificates of Suitability of the European Pharmacopoeia.Our key technologies are: Solid Phase Synthesis. HPLC Purification. Lyophilisation under GMP conditions. Sterile Peptides.We concentrate our efforts in the following activities: Synthesis under cGMP of Bulk Generic Peptides. Custom API Peptides.
